Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience
Conclusion:
Treatment with PD-1 inhibitors seems to have an efficacy signal and be well tolerated in PLWHIV, including impact on CD4+ lymphocyte count and HIV load, that should be monitored during treatment course (regarding real-life experience).
Source: AIDS - Category: Infectious Diseases Tags: FAST TRACK Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | France Health | Head and Neck Cancer | HIV AIDS | Immunotherapy | Infectious Diseases | Lung Cancer | Melanoma | Skin Cancer | Toxicology